Fig. 6From: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort studyTime-to-first hospital readmission following initiation of FF/UMEC/VI. FF/UMEC/VI fluticasone furoate/umeclidinium/vilanterol, CI confidence interval, COPD chronic obstructive pulmonary diseaseBack to article page